Rallybio Corp. (RLYB)
16.64
+0.24
(+1.46%)
USD |
NASDAQ |
Oct 23, 16:00
16.48
-0.16
(-0.96%)
After-Hours: 20:00
Rallybio Net Income (Quarterly) : 43.66M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.66M |
| March 31, 2026 | -8.278M |
| December 31, 2025 | -5.852M |
| September 30, 2025 | 16.02M |
| June 30, 2025 | -9.703M |
| March 31, 2025 | -9.439M |
| December 31, 2024 | -11.04M |
| September 30, 2024 | -11.47M |
| June 30, 2024 | -16.24M |
| March 31, 2024 | -19.03M |
| December 31, 2023 | -20.24M |
| September 30, 2023 | -18.37M |
| June 30, 2023 | -18.63M |
| Date | Value |
|---|---|
| March 31, 2023 | -17.32M |
| December 31, 2022 | -16.20M |
| September 30, 2022 | -18.37M |
| June 30, 2022 | -17.58M |
| March 31, 2022 | -14.50M |
| December 31, 2021 | -12.42M |
| September 30, 2021 | -10.20M |
| June 30, 2021 | -11.13M |
| March 31, 2021 | -13.28M |
| December 31, 2020 | -10.52M |
| September 30, 2020 | -7.155M |
| June 30, 2020 | -4.893M |
| March 31, 2020 | -3.881M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | -43.66M |
| EPS Diluted (Quarterly) | 7.531 |
| Enterprise Value | -4.542M |
| Earnings Yield | 46.95% |
| Normalized Earnings Yield | 14.90 |